Johnson & Johnson Innovative Medicine

The pharmaceutical business of Johnson & Johnson, pursuing science-led drug discovery and development in oncology, immunology, and neuroscience.

Location: Titusville, NJ, USA

2 models(1 RNA, 1 Small molecule, 1 Protein)

Models (2)

Johnson & Johnson Innovative Medicine / University of Amsterdam

Released September 29, 2025

———

mRNA language model with a hyperbolic prediction head encoding the codon-amino-acid hierarchy, beating Euclidean baselines on 9 of 10 property tasks.

RNA

University of Texas at Arlington / Johnson & Johnson Innovative Medicine

Released September 26, 2025

———

Multimodal drug-target interaction model aligning SMILES, molecule text, taxonomy, and protein sequence with a Gramian volume contrastive objective.

Small moleculeProtein